Top Glove Corporation Bhd. (TGLVY)
USD 1.06
(0.0%)
USD 1.06
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 39.77 Million MYR | -63.28% |
| 2022 | 108.33 Million MYR | -33.99% |
| 2021 | 164.12 Million MYR | -30.46% |
| 2020 | 236.01 Million MYR | -82.89% |
| 2019 | 1.37 Billion MYR | 3.68% |
| 2018 | 1.33 Billion MYR | 2054.43% |
| 2017 | 61.75 Million MYR | -24.36% |
| 2016 | 81.63 Million MYR | -22.76% |
| 2015 | 105.69 Million MYR | 4061.14% |
| 2014 | 2.54 Million MYR | -9.58% |
| 2013 | 2.8 Million MYR | -0.21% |
| 2012 | 2.81 Million MYR | -1.26% |
| 2011 | 2.85 Million MYR | -5.75% |
| 2010 | 3.02 Million MYR | -66.24% |
| 2009 | 8.96 Million MYR | -89.66% |
| 2008 | 86.62 Million MYR | -32.57% |
| 2007 | 128.46 Million MYR | -12.27% |
| 2006 | 146.43 Million MYR | 109.5% |
| 2005 | 69.89 Million MYR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 1.17 Billion MYR | 0.0% |
| 2024 Q1 | 35.73 Million MYR | -26.34% |
| 2024 Q2 | 1.17 Billion MYR | -100.0% |
| 2023 Q2 | 83.45 Million MYR | -16.74% |
| 2023 Q1 | 100.23 Million MYR | -7.48% |
| 2023 Q3 | 39.75 Million MYR | -52.36% |
| 2023 FY | 39.77 Million MYR | -63.28% |
| 2023 Q4 | 39.77 Million MYR | 0.05% |
| 2022 Q3 | 123.16 Million MYR | -6.24% |
| 2022 FY | 108.33 Million MYR | -33.99% |
| 2022 Q1 | 149.85 Million MYR | -8.7% |
| 2022 Q4 | 108.33 Million MYR | -12.04% |
| 2022 Q2 | 131.36 Million MYR | -12.34% |
| 2021 Q2 | 181.24 Million MYR | 14.86% |
| 2021 Q4 | 164.12 Million MYR | -7.88% |
| 2021 FY | 164.12 Million MYR | -30.46% |
| 2021 Q3 | 178.17 Million MYR | -1.69% |
| 2021 Q1 | 157.79 Million MYR | -33.14% |
| 2020 FY | 236.01 Million MYR | -82.89% |
| 2020 Q1 | 1.31 Billion MYR | -5.03% |
| 2020 Q3 | 962.59 Million MYR | -28.19% |
| 2020 Q4 | 236.01 Million MYR | -75.48% |
| 2020 Q2 | 1.34 Billion MYR | 2.32% |
| 2019 Q4 | 1.37 Billion MYR | 0.07% |
| 2019 FY | 1.37 Billion MYR | 3.68% |
| 2019 Q1 | 1.34 Billion MYR | 0.77% |
| 2019 Q3 | 1.37 Billion MYR | 11.67% |
| 2019 Q2 | 1.23 Billion MYR | -7.93% |
| 2018 Q1 | 51.49 Million MYR | -16.61% |
| 2018 Q4 | 1.33 Billion MYR | -7.93% |
| 2018 Q3 | 1.44 Billion MYR | 2702.7% |
| 2018 FY | 1.33 Billion MYR | 2054.43% |
| 2018 Q2 | 51.55 Million MYR | 0.12% |
| 2017 Q2 | 76.49 Million MYR | -7.47% |
| 2017 Q1 | 82.66 Million MYR | 1.26% |
| 2017 Q3 | 67.95 Million MYR | -11.16% |
| 2017 FY | 61.75 Million MYR | -24.36% |
| 2017 Q4 | 61.75 Million MYR | -9.13% |
| 2016 FY | 81.63 Million MYR | -22.76% |
| 2016 Q4 | 81.63 Million MYR | -6.12% |
| 2016 Q3 | 86.96 Million MYR | -8.41% |
| 2016 Q2 | 94.94 Million MYR | -6.78% |
| 2016 Q1 | 101.84 Million MYR | -3.64% |
| 2015 Q3 | 112.12 Million MYR | 1.21% |
| 2015 FY | 105.69 Million MYR | 4061.14% |
| 2015 Q1 | 69.06 Million MYR | 2619.02% |
| 2015 Q2 | 110.77 Million MYR | 60.4% |
| 2015 Q4 | 105.69 Million MYR | -5.73% |
| 2014 Q1 | 2.7 Million MYR | -3.7% |
| 2014 Q3 | 2.62 Million MYR | -3.1% |
| 2014 Q2 | 2.71 Million MYR | 0.22% |
| 2014 FY | 2.54 Million MYR | -9.58% |
| 2014 Q4 | 2.54 Million MYR | -3.31% |
| 2013 Q4 | 2.8 Million MYR | 6.56% |
| 2013 Q2 | 2.68 Million MYR | 0.45% |
| 2013 Q1 | 2.67 Million MYR | -4.97% |
| 2013 FY | 2.8 Million MYR | -0.21% |
| 2013 Q3 | 2.63 Million MYR | -1.9% |
| 2012 FY | 2.81 Million MYR | -1.26% |
| 2012 Q3 | 2.85 Million MYR | 3.44% |
| 2012 Q2 | 2.76 Million MYR | 0.0% |
| 2012 Q4 | 2.81 Million MYR | -1.4% |
| 2011 Q4 | 2.85 Million MYR | 0.0% |
| 2011 FY | 2.85 Million MYR | -5.75% |
| 2010 FY | 3.02 Million MYR | -66.24% |
| 2009 FY | 8.96 Million MYR | -89.66% |
| 2008 FY | 86.62 Million MYR | -32.57% |
| 2007 FY | 128.46 Million MYR | -12.27% |
| 2006 FY | 146.43 Million MYR | 109.5% |
| 2005 FY | 69.89 Million MYR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | -Infinity% |
| Ansell Limited | 705.27 Million USD | 94.36% |
| Ansell Limited | 706.6 Million USD | 94.37% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -77.493% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | - USD | -Infinity% |
| Psykey, Inc. | 625 Thousand USD | -6264.64% |
| ConvaTec Group Plc | 1.22 Billion USD | 96.753% |
| ConvaTec Group Plc | 1.22 Billion USD | 96.758% |
| Encision Inc. | 67.33 Thousand USD | -58975.383% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 382.83 Thousand USD | -10290.584% |
| LifePoint, Inc. | 151.73 Thousand USD | -26116.273% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | -709.503% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | -6368.13% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | -22003.988% |
| SmileDirectClub, Inc. | 849.37 Million USD | 95.317% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | 81.128% |
| SheerVision, Inc. | - USD | -Infinity% |
| United Health Products, Inc. | 48.48 Thousand USD | -81937.163% |
| Vasamed, Inc. | 18.95 Thousand USD | -209815.567% |
| Wearable Health Solutions, Inc. | 18.46 Thousand USD | -215294.195% |
| Yubo International Biotech Limited | 390.44 Thousand USD | -10088.119% |